Red Chip Enterprises
Red Chip Enterprises is a privately held specialty pharmacy founded in 2001 that provides integrated dispensing, reimbursement, and patient care services to U.S. Bleeding Disorder Centers operating 340B outpatient programs for rare hemophilia and clotting disorders.
- Company typePrivate
- Founded2001
- HeadquartersIrvine, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Red Chip Enterprises does
Red Chip Enterprises is a privately held, specialty pharmacy and healthcare services company founded in 2001 and headquartered in Irvine, California. The company provides integrated pharmacy, reimbursement, and patient care services to Bleeding Disorder Centers (BDCs) and Hemophilia Treatment Centers (HTCs) operating 340B outpatient programs for rare bleeding and clotting disorders. It is licensed as a specialty pharmacy in all 50 states and supports over 2,000 patients with complex, high-cost therapies, including hemophilia gene therapies such as Hemgenix and Roctavian.
The company's core offerings are organized around three service lines — Specialty Pharmacy, Reimbursement Solutions, and Pharmaceutical Partner Services — supported by five operational teams covering payer contracting, patient care coordination, pharmacy dispensing, billing and collections, and financial reporting. Underlying technology assets include a proprietary monthly reporting suite with 25+ data points and a bill-to/ship-to inventory model that preserves BDC ownership and creates an auditable chain of custody. Red Chip holds URAC and ACHC specialty pharmacy accreditations and has received the URAC Pioneer in Excellence Award annually from 2021 through 2024.
Red Chip generates revenue through three primary streams: transaction fees on specialty medication dispensing passed through to BDC programs, outcome-based compensation tied to successful collections on complex claims, and managed-services arrangements with pharmaceutical manufacturers for limited-distribution drug delivery. Pricing is not publicly disclosed but is structured as pay-as-you-go with no setup or implementation fees for reimbursement services. The company sells exclusively through direct B2B engagement, supported by participation in industry conferences (340B Coalition, THSNA, Asembia, HTRS) and referral networks within the small U.S. HTC/BDC ecosystem.
Red Chip Enterprises firmographics
Firmographics- Name
- Red Chip Enterprises
- Legal name
- Red Chip Enterprises
- Website
- https://redchip.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Red Chip Enterprises is a privately held specialty pharmacy founded in 2001 that provides integrated dispensing, reimbursement, and patient care services to U.S. Bleeding Disorder Centers operating 340B outpatient programs for rare hemophilia and clotting disorders.
- Ownership category
- akta.pro rank
Red Chip Enterprises industry classification
Industry- Product category
- Specialty Pharmacy Services / 340B Program Management
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Hospital & Medical Service Plans (6324)
- akta.pro primary industry
- 340B Program Administration & Contract Pharmacy Services (HLAFALAL)
- akta.pro secondary industries
- Specialty Pharmacy Benefit Management (Specialty PBM) (HLAEAKAE), Claims Processing, Adjudication & Payment Integrity (HLAEAKAC), 340B Program Administration & Support (HLAEAKAJ)
Keywords
Where Red Chip Enterprises is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Red Chip Enterprises business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Specialty Pharmacy Dispensing Services: Red Chip dispenses specialty medications (rare disease, bleeding disorders, gene therapies) as a licensed specialty pharmacy in all 50 states. Revenue is generated through billing and collecting on medical and pharmacy claims (UB-04, CMS-1500, NCPDP), with reimbursement passed through to the BDC program minus a service fee.
- Reimbursement Solutions (Standalone Billing & Collections): Standalone reimbursement and billing services for complex, high-dollar claims. Compensation is tied directly to successful collections — Red Chip does not get paid until the BDC program gets paid. No setup or implementation costs. Designed for providers treating rare, high-dollar conditions.
- Pharmaceutical Manufacturer Partnerships: Partnership with pharmaceutical manufacturers as a sole-source or limited-distribution specialty pharmacy option, executing compliant, patient-focused therapy delivery. Provides manufacturers with visibility, accountability, and reporting across the therapy lifecycle.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Outcome Based/ Performance | Pay-as-you-go | Outcome-based Reimbursement Services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Red Chip Enterprises product offering
Product offeringCore offering
Red Chip Enterprises provides specialty pharmacy dispensing, 340B program management, and complex claims reimbursement services to Bleeding Disorder Centers (BDCs) and pharmaceutical manufacturers across all 50 states. The company bills and collects on high-dollar medical and pharmacy claims (UB-04, CMS-1500, NCPDP), supports prior authorizations, patient care coordination, and gene therapy reimbursement, and supplies audit-ready monthly financial reporting. It also partners with manufacturers as a sole-source or limited-distribution specialty pharmacy for rare and complex therapies.
Product overview
Red Chip Enterprises operates as a nationally licensed specialty pharmacy and integrated healthcare services partner offering a portfolio of coordinated services. The core offerings include Specialty Pharmacy (340B program management), Reimbursement Solutions (complex claims handling), and Pharmaceutical Partner Services. These are supported by five specialized sub-product teams: Payer Team (contract negotiation), Patient Care Team (patient coordination), Pharmacy Team (dispensing/delivery), Billing & Collection Team (revenue recovery at 99.95% collection rate), and Financial Data & Reporting Team (audit-ready 340B reporting).
Differentiator
Problem solved
Functional benefit
Products and services
- Specialty Pharmacy Fully integrated specialty pharmacy service supporting Bleeding Disorder Centers (BDCs) as a business partner for 340B outpatient programs. Covers prior authorizations, eligibility, compliant dispensing, patient care support, reimbursement, and financial reporting across all 50 states. For BDCs/HTCs operating 340B programs and the rare bleeding disorder patients they serve.
- Reimbursement Solutions Standalone reimbursement and billing service for complex, high-dollar medical and pharmacy claims (UB-04, CMS-1500, NCPDP), addressing delays, denials, short pays, prior authorization, and gene therapy reimbursement. Compensation tied to successful collections with no setup or implementation costs. For providers treating rare, high-dollar conditions.
- Pharmaceutical Partner Services Sole-source or limited-distribution specialty pharmacy partnership for pharmaceutical manufacturers delivering rare and complex therapies (including gene therapies such as Hemgenix and Roctavian). Provides high-touch patient care, adherence management, REMS support, and program performance reporting across the therapy lifecycle. For pharmaceutical manufacturers producing rare disease and gene therapies.
Quantifiable outcome
- 99.95% collection rate on high-dollar specialty claims
- +6 more outcomes
Companies that use Red Chip Enterprises
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Red Chip Enterprises technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Red Chip Enterprises partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered supporting.
- Hemophilia and Thrombosis Research Society (HTRS)supportingRed Chip proudly supports HTRS and its mission to advance clinical research, education, and collaboration in bleeding and clotting disorders. The company believes strong research and shared knowledge are essential to improving patient outcomes and supporting clinicians who care for this community.
- Thrombosis & Hemostasis Summit of North America (THSNA)supportingRed Chip is a proud supporter of THSNA, which brings together clinicians, researchers, and care teams dedicated to advancing thrombosis and hemostasis care. The company values engagement with field leaders and meaningful collaboration that benefits patients and families.
- AsembiasupportingRed Chip participates in Asembia to stay connected to the evolving specialty pharmacy landscape. Engagement focuses on remaining current on industry standards, payer dynamics, and emerging therapies to better support patients, providers, and partners.
- 340B CoalitionsupportingRed Chip actively participates in 340B Coalition meetings to support program integrity, education, and advocacy. These forums help ensure the 340B Program continues to serve its intended purpose of strengthening care for vulnerable patient populations.
Scale indicators8 records
Recent moves5 records
Expansion highlights5 records
Red Chip Enterprises competitors and assessment
Company assessmentDirect peers
- Soleo Health: Specialty pharmacy and home infusion provider serving complex, high-cost therapies across multiple rare conditions. Comparable to Red Chip in high-touch patient care model and specialty drug reimbursement focus.
- PANTHERx Rare Pharmacy: Specialty pharmacy focused exclusively on rare and orphan diseases, including bleeding disorders and gene therapies. Directly comparable to Red Chip in mission, patient mix, and limited-distribution pharma partnerships.
- Trellis Rx (CPS Solutions): Specialty pharmacy services company embedded within hospital outpatient programs, with strong 340B program administration expertise. Closely comparable to Red Chip's integrated BDC partnership model.
- Curascript (formerly Smith Drug Company): Specialty distribution and pharmacy services provider with strong 340B and limited-distribution drug capabilities. Comparable to Red Chip in specialty channel services and 340B program support.
Broad incumbents
- RxBenefits: Pharmacy benefit administrator serving employer health plans with specialty drug management. Comparable to Red Chip's reimbursement administration expertise, though operating at a much larger employer-plan scale.
- CVS Specialty: Specialty pharmacy arm of CVS Health serving complex, high-cost conditions. Comparable to Red Chip in dispensing and patient care coordination, with substantially broader payer access and scale.
- Diplomat Pharmacy (Optum Specialty Pharmacy): Large specialty pharmacy (now part of Optum/UnitedHealth) serving rare and chronic conditions. Comparable to Red Chip in specialty dispensing and patient support, but at vastly larger scale and with payer-owned distribution.
- Accredo (Express Scripts / Cigna): One of the largest U.S. specialty pharmacies, owned by Cigna/Express Scripts. Directly relevant as a competitor for rare-disease and gene therapy patients, with superior payer network leverage.
- Biologics by McKesson: Specialty pharmacy and oncology services division of McKesson, serving complex therapy patients across rare diseases. Comparable in rare-disease dispensing and manufacturer partnership model.
Emerging players
- PharmaCord: Patient support services and limited-distribution pharmacy provider for pharmaceutical manufacturers, particularly in rare and specialty therapies. Comparable to Red Chip's manufacturer partnership and patient onboarding services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Red Chip Enterprises social profiles
Digital presenceRed Chip Enterprises compliance and trust
Trust signalCompliance6 records
Red Chip Enterprises financial estimates
Financial estimateRevenue estimate
Valuation estimate
Red Chip Enterprises leadership team
Management profileNumber of profiles
Red Chip Enterprises funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Red Chip Enterprises M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Red Chip Enterprises
What does Red Chip Enterprises do?
Red Chip Enterprises provides specialty pharmacy dispensing, 340B program management, and complex claims reimbursement services to Bleeding Disorder Centers (BDCs) and pharmaceutical manufacturers across all 50 states. The company bills and collects on high-dollar medical and pharmacy claims (UB-04, CMS-1500, NCPDP), supports prior authorizations, patient care coordination, and gene therapy reimbursement, and supplies audit-ready monthly financial reporting. It also partners with manufacturers as a sole-source or limited-distribution specialty pharmacy for rare and complex therapies.
Is Red Chip Enterprises a public or private company?
Red Chip Enterprises is a private company. It is classified as unknown and is currently operating.
When was Red Chip Enterprises founded?
Red Chip Enterprises was founded in 2001. It employs 11 to 50 people.
Where is Red Chip Enterprises based?
Red Chip Enterprises is headquartered in Irvine, United States, in the North America region.
How does Red Chip Enterprises make money?
Three revenue lines are on record. Specialty Pharmacy Dispensing Services are the primary driver. The others are reimbursement Solutions (Standalone Billing & Collections) and pharmaceutical Manufacturer Partnerships.
Who are Red Chip Enterprises's main competitors?
Direct peers on record are Soleo Health, PANTHERx Rare Pharmacy, Trellis Rx (CPS Solutions) and Curascript (formerly Smith Drug Company). Broad incumbents are RxBenefits, CVS Specialty, Diplomat Pharmacy (Optum Specialty Pharmacy), Accredo (Express Scripts / Cigna) and Biologics by McKesson. PharmaCord is listed as an emerging player.
Does Red Chip Enterprises have an API?
No public API is recorded for Red Chip Enterprises.
What industry is Red Chip Enterprises in?
Red Chip Enterprises's product category is Specialty Pharmacy Services / 340B Program Management. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HLAEAKAE, Specialty Pharmacy Benefit Management (Specialty PBM). Its NAICS code is 524292 and its SIC code is 6324.